Evotec SE (EVO) Financials
EVO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 2.4 billion | 1.2 billion |
2023-06-30 | 2.5 billion | 1.2 billion |
2023-03-31 | 2.5 billion | 1.2 billion |
2022-12-31 | 2.4 billion | 1.1 billion |
EVO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -26.6 million | ? |
2023-06-30 | -59.6 million | ? |
2023-03-31 | -62.9 million | 10.8 million |
2022-12-31 | -61.9 million | ? |
EVO Net Income
No data available :(
EVO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 655.5 million | - | - |
2023-06-30 | 688.3 million | - | - |
2023-03-31 | 795.7 million | - | - |
2022-12-31 | 783.4 million | - | 189.8 million |
EVO Shares Outstanding
EVO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 48.6 million | 18.5 million | 41.6 million | - |
2023-06-30 | 56.6 million | 13.5 million | 49.6 million | - |
2023-03-31 | 26.3 million | 23.2 million | - | - |
2022-12-31 | 25.9 million | 22.9 million | 49.7 million | - |
EVO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 207.8 million | 167.7 million |
2023-06-30 | 185.2 million | 134.8 million |
2023-03-31 | 262.4 million | 172.5 million |
2022-12-31 | 258.3 million | 169.8 million |
EVO
Price: $5.27
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.29 USD
P/E Ratio: -26
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 14985
Market Capitalization: 2.7 billion
Average Dividend Frequency: 12